Biocon, Viatris Receive EC Nod For Biosimilar Bevacizumab
Biocon Biologics Ltd, a subsidiary of Bengaluru-headquartered Biocon Ltd, has announced that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc.,...
Download Unicorn Signals App
Powered By EquityPandit
